Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer

JOURNAL ARTICLE published March 2018 in Annals of Oncology

Research funded by Susan G. Komen for the Cure (CCR15224703)

Authors: R. Condorelli | L. Spring | J. O’Shaughnessy | L. Lacroix | C. Bailleux | V. Scott | J. Dubois | R.J. Nagy | R.B. Lanman | A.J. Iafrate | F. Andre | A. Bardia